Home Life Style Malignant Tumors Have Several Gene Types, According To Study

Malignant Tumors Have Several Gene Types, According To Study

Affiliate Disclosure

In compliance with the FTC guidelines, please assume the following about all links, posts, photos and other material on this website: (...)

3643
Advertisements

Malignant Tumors

According to an article published in the New England Journal of Medicine, a malignant tumor has several types of genes . Therefore,  a simple biopsy of a tumor can not assure the clinician that the treatment works for the entire tumor. This explains the failure of many cancer treatments.
The researchers made this discovery during several studies on renal tumors. Scientists have investigated the genome of a tumor by taking pieces from different regions of the same tumors and compared samples taken from four different parts of the tumor and metastatic tumors found in other organs. Surprisingly, two thirds of the genes identified were not the same.

Cancer Genes

Cancer Genes

Lead author Professor Charles Swanton of the UCL Cancer Institute and Cancer Research UK’s London Research Institute, points out that this is the first time a genome of a tumor is successfully sequenced. He added that the next step is the discovery of drugs that limit the range by controlling the underlying tumor mutations.

Malignant tumor develops as a result of uncontrolled proliferation of a group of cells that have the ability to invade other tissues of the body, either by invasion or by metastasis. This uncontrolled growth is due to abnormalities occurring in the DNA of a cell. There are several causes of these abnormalities, such as inserting viruses in DNA structure, for example Epstein Barr, or the occurrence of spontaneous mutations.

It is very important to apply a differential treatment  as the primary tumor may be genetically different from metastatic spread of tumors in the rest of the body. In the study, the scientists found 118 different mutations, 40 of them were found in all biopsies, 53 were found only in some biopsies and 25 were found in one biopsy. This finding is extremely valuable in fighting cancer because it allows researchers to focus treatment on common mutations found in all biopsy samples. Targeting  the treatment on the cells responsible for growth is  the way to success in combating cancer. That explains why primary tumor removal increases patient survival by preventing relapse.

Dr Lesley Walker, Cancer Research UK’s director of cancer information,  stresses the idea  that it is very important to implement in the health system  this new method of investigating tumors, namely genetic analysis. By sequencing the genome of a tumor clinicians can use a personalized treatment and hopes of success are much higher. He added that plans to replicate the findings in a larger group of patients as part of Cancer Research UK’s Genomics Initiative.